Journal of Oncology Research and Treatment
Open Access

OMICS International welcomes proposals for creating special issues that fall within the scope of engineering journals published by OMICS. The special issues should aim at exploring recent advances in Cancer research, findings, treatments, and other research areas concerned with all branches in oncology. We seek original unpublished works that represent specific areas of research which can widen the scope of technological applications to all fields of oncology.Proposal PreparationSpecial issues will be released on a monthly basis and proposals will be accepted accordingly. All proposals should include the following information:

• Title of the proposed special issue
• Purpose and current relevance
• List of topics to be covered
• List of potential contributors
• Guest Editor(s) and Reviewers
• Address, phone, e-mail, and fax of guest editors and reviewers
• Tentative deadlines for submission and review process (Timeline for submission, review, and final acceptance)

All proposals should be submitted to https://www.scholarscentral.org/submissions/advances-oncology-research-treatments.html or send as an e-mail attachment to the Editorial Office at manuscript@omicsonline.org

Role of EB Members

• Review the special issue proposals for relevance to current research in the concerned field.
• Recommend suitable proposals and their guest editors along with their biographies.

Once a proposal has been accepted by the EB members for creating a special issue, the corresponding guest editors will be responsible for handling and processing of the special issue articles.Role of Guest Editor(s)

• State the importance of the proposed special issue theme and explain how the special issue articles will contribute towards advancing the scope of the journal.
• Suggest potential authors and invite them for contributing relevant articles for the proposed special issue.
• Suggest a minimum of 3-5 reviewers for the manuscripts submitted towards the special issue.
• Carry out all communications with potential authors and reviewers concerning author guidelines for manuscript preparation and reviewing.
• Prepare a timeline and schedule for the release of special issue articles. This should include a timeline for manuscript preparation, review process, and final submission.
• Oversee the submission of final edited versions of the contributing articles along with the contact information of all corresponding authors.
• Include a short editorial for the topic of interest written either by the guest editor or by any of the contributors.

Submission Process

• Special issue articles can include both original unpublished research articles and review articles related to the specific theme.
• Manuscripts will be accepted for publishing in the special issue only after getting approved by the peer review committee [selected by the guest editor(s)].
• All the articles in special issues should strictly adhere to journal style and formatting.
• Each special issue can be created with 10-15 articles.
• All accepted manuscripts can be submitted online via https://www.scholarscentral.org/submissions/advances-oncology-research-treatments.html Submission should be accompanied by a cover letter with reference to the concerned special issue theme.
• Accepted manuscripts submitted before the deadline will be published within the given timeframe for the respective journal publication.

Once accepted and published, all special issues will be released under an open access system through OMICS International  and will be freely available for reading, downloading, and printing.

For further information on special issue guidelines and submission process, please contact manuscript@omicsonline.org

Note: Authors are sole responsible for any scientific misconduct including plagiarism in their research articles; publisher is not responsible for any scientific misconduct happened in any published research article. As a publisher we will follow strictly scientific guidelines and EIC’s advice to retract or erratum of any article at any time if scientific misconduct or errors happened in any articles.